537 related articles for article (PubMed ID: 28293234)
1. Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome.
Liu R; Zhang C; Shi Y; Zhang F; Li L; Wang X; Ling Y; Fu H; Dong W; Shen J; Reeves A; Greenberg AS; Zhao L; Peng Y; Ding X
Front Microbiol; 2017; 8():324. PubMed ID: 28293234
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
3. High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.
Wang X; Xu T; Liu R; Wu G; Gu L; Zhang Y; Zhang F; Fu H; Ling Y; Wei X; Luo Y; Shen J; Zhao L; Peng Y; Zhang C; Ding X
Front Endocrinol (Lausanne); 2021; 12():806331. PubMed ID: 35185786
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
6. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
8. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.
Liang Y; Ming Q; Liang J; Zhang Y; Zhang H; Shen T
Can J Physiol Pharmacol; 2020 Nov; 98(11):803-809. PubMed ID: 32150694
[TBL] [Abstract][Full Text] [Related]
9. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients.
Chen F; Chen Z; Chen M; Chen G; Huang Q; Yang X; Yin H; Chen L; Zhang W; Lin H; Ou M; Wang L; Chen Y; Lin C; Xu W; Yin G
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):60. PubMed ID: 34267209
[TBL] [Abstract][Full Text] [Related]
10. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
11. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
13. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z
BMC Med; 2023 Aug; 21(1):302. PubMed ID: 37559119
[TBL] [Abstract][Full Text] [Related]
14. Characteristic gut microbiota and predicted metabolic functions in women with PCOS.
Zhou L; Ni Z; Cheng W; Yu J; Sun S; Zhai D; Yu C; Cai Z
Endocr Connect; 2020 Jan; 9(1):63-73. PubMed ID: 31972546
[TBL] [Abstract][Full Text] [Related]
15. Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome.
Saydam BO; Yildiz BO
Curr Pharm Des; 2016; 22(36):5572-5587. PubMed ID: 27426125
[TBL] [Abstract][Full Text] [Related]
16. Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: A systematic review and meta-analysis.
Zou Y; Liao R; Cheng R; Chung H; Zhu H; Huang Y
Microb Pathog; 2023 Nov; 184():106370. PubMed ID: 37739322
[TBL] [Abstract][Full Text] [Related]
17. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
18.
Luo M; Chen Y; Pan X; Chen H; Fan L; Wen Y
Front Immunol; 2023; 14():1137089. PubMed ID: 37275915
[TBL] [Abstract][Full Text] [Related]
19. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis.
Sherman SB; Sarsour N; Salehi M; Schroering A; Mell B; Joe B; Hill JW
Gut Microbes; 2018; 9(5):400-421. PubMed ID: 29469650
[TBL] [Abstract][Full Text] [Related]
20. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
